Two Sigma Advisers’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,550
| Closed | -$61.8K | – | 2717 |
|
|
2024
Q1 | $61.8K | Buy |
+11,550
| New | +$61.8K | ﹤0.01% | 2338 |
|
|
2022
Q2 | – | Sell |
-10,670
| Closed | -$127K | – | 2924 |
|
|
2022
Q1 | $127K | Buy |
10,670
+1,610
| +18% | +$19.2K | ﹤0.01% | 2470 |
|
|
2021
Q4 | $295K | Sell |
9,060
-8,210
| -48% | -$267K | ﹤0.01% | 2148 |
|
|
2021
Q3 | $772K | Sell |
17,270
-8,340
| -33% | -$373K | ﹤0.01% | 1734 |
|
|
2021
Q2 | $1.4M | Sell |
25,610
-3,970
| -13% | -$216K | ﹤0.01% | 1481 |
|
|
2021
Q1 | $2.21M | Buy |
29,580
+6,500
| +28% | +$486K | 0.01% | 1217 |
|
|
2020
Q4 | $2.5M | Buy |
23,080
+4,870
| +27% | +$528K | 0.01% | 1140 |
|
|
2020
Q3 | $1.61M | Sell |
18,210
-20
| -0.1% | -$1.77K | ﹤0.01% | 1275 |
|
|
2020
Q2 | $1.94M | Buy |
18,230
+10,190
| +127% | +$1.09M | 0.01% | 1215 |
|
|
2020
Q1 | $477K | Sell |
8,040
-2,510
| -24% | -$149K | ﹤0.01% | 1832 |
|
|
2019
Q4 | $729K | Buy |
+10,550
| New | +$729K | ﹤0.01% | 1709 |
|
|
2019
Q3 | – | Sell |
-3,800
| Closed | -$352K | – | 2425 |
|
|
2019
Q2 | $352K | Sell |
3,800
-300
| -7% | -$27.8K | ﹤0.01% | 1949 |
|
|
2019
Q1 | $375K | Sell |
4,100
-980
| -19% | -$89.6K | ﹤0.01% | 1906 |
|
|
2018
Q4 | $283K | Sell |
5,080
-460
| -8% | -$25.6K | ﹤0.01% | 2013 |
|
|
2018
Q3 | $660K | Sell |
5,540
-1,860
| -25% | -$222K | ﹤0.01% | 1686 |
|
|
2018
Q2 | $756K | Buy |
+7,400
| New | +$756K | ﹤0.01% | 1735 |
|
|
2018
Q1 | – | Sell |
-1,080
| Closed | -$105K | – | 2446 |
|
|
2017
Q4 | $105K | Buy |
+1,080
| New | +$105K | ﹤0.01% | 2145 |
|